SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CBD Life Sciences Inc. – ‘1-A/A’ on 1/15/20 – ‘EX1A-12 OPN CNSL’

On:  Wednesday, 1/15/20, at 5:23pm ET   ·   Accession #:  1683168-20-147   ·   File #:  24-11005

Previous ‘1-A’:  ‘1-A/A’ on 10/17/19   ·   Next:  ‘1-A/A’ on 2/11/20   ·   Latest:  ‘1-A’ on 8/18/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/15/20  CBD Life Sciences Inc.            1-A/A                  3:1.7M                                   GlobalOne Filings Inc/FA

Pre-Qualification Amendment to Offering Statement — Reg. A   —   Form 1-A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 1-A/A       Pre-Qualification Amendment to Offering Statement   HTML      8K 
                -- Reg. A -- primary_doc.xml                                     
 2: PART II AND III  Offering Statement - Parts II & III -- Reg. A  HTML    914K 
                - Form 1-A                                                       
 3: EX1A-12 OPN CNSL  Legal Opinion                                 HTML      8K 


‘EX1A-12 OPN CNSL’   —   Legal Opinion


This is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 12.1

 

John E. Lux, Esq.
Attorney at Law
1629 K Street, Suite 300
Washington, DC 20006
(202) 780-1000
Admitted in Maryland and the District of Columbia

 

 

January 15, 2020

 

Board of Directors

8350 Ashlane Way, Suite 104

The Woodlands, Texas 77382

 

 

Ladies and Gentlemen:

 

I have acted, at your request, as special counsel to CBD Life Sciences, Inc., a Nevada corporation, (“CBD Life Sciences, Inc.”) for the purpose of rendering an opinion as to the legality of 400,000,000 shares of CBD Life Sciences, Inc. common stock, par value $0.001 per share to be offered and distributed by CBD Life Sciences, Inc. (the “Shares”), pursuant to an Offering Statement to be filed under Regulation A of the Securities Act of 1933, as amended, by CBD Life Sciences, Inc. with the U.S. Securities and Exchange Commission (the "SEC") on Form 1-A, for the purpose of registering the offer and sale of the Shares (“Offering Statement”).

 

For the purpose of rendering my opinion herein, I have reviewed statutes of the State of Nevada, to the extent I deem relevant to the matter opined upon herein, certified or purported true copies of the Articles of Incorporation of CBD Life Sciences, Inc. and all amendments thereto, the By-Laws of CBD Life Sciences, Inc., selected proceedings of the board of directors of CBD Life Sciences, Inc. authorizing the issuance of the Shares, certificates of officers of CBD Life Sciences, Inc. and of public officials, and such other documents of CBD Life Sciences, Inc. and of public officials as I have deemed necessary and relevant to the matter opined upon herein. I have assumed, with respect to persons other than directors and officers of CBD Life Sciences, Inc., the due and proper election or appointment of all persons signing and purporting to sign the documents in their respective capacities, as stated therein, the genuineness of all signatures, the conformity to authentic original documents of the copies of all such documents submitted to me as certified, conformed and photocopied, including the quoted, extracted, excerpted and reprocessed text of such documents.

 

Based upon the review described above, it is my opinion that the Shares are duly authorized and when, as and if issued and delivered by CBD Life Sciences, Inc. against payment therefore, as described in the Offering Statement, will be validly issued, fully paid and non-assessable.

 

I have not been engaged to examine, nor have I examined, the Offering Statement for the purpose of determining the accuracy or completeness of the information included therein or the compliance and conformity thereof with the rules and regulations of the SEC or the requirements of Form 1-A, and I express no opinion with respect thereto. My forgoing opinion is strictly limited to matters of Nevada corporation law; and, I do not express an opinion on the federal law of the United States of America or the law of any state or jurisdiction therein other than Nevada, as specified herein.

 

I hereby consent to the filing of this opinion as Exhibit 12.1 to the Offering Statement and to the reference to our firm under the caption “Legal Matters” in the Offering Circular constituting a part of the Offering Statement. We assume no obligation to update or supplement any of the opinion set forth herein to reflect any changes of law or fact that may occur following the date hereof.

 

Very truly yours,

 

/s/ John E. Lux

 

John E. Lux    

 

 


Dates Referenced Herein

This ‘1-A/A’ Filing    Date    Other Filings
Filed on:1/15/20None on these Dates
 List all Filings 
Top
Filing Submission 0001683168-20-000147   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 5:02:10.1am ET